Parexel is among the world’s largest clinical research organizations, providing the full range of Phase I to IV clinical development services to help life-saving treatments reach patients faster. Leveraging the breadth of its clinical, regulatory and therapeutic expertise, Parexel’s team of more than 21,000 global professionals collaborates with biopharmaceutical leaders, emerging innovators and sites to design and deliver clinical trials with patients in mind, increasing access and participation to make clinical research a care option for anyone, anywhere.
Parexel
